Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials

Detalles Bibliográficos
Autor principal: Gottardo, Nicholas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807471/
https://www.ncbi.nlm.nih.gov/pubmed/36403175
http://dx.doi.org/10.1007/s00401-022-02518-0
_version_ 1784862726609174528
author Gottardo, Nicholas G.
author_facet Gottardo, Nicholas G.
author_sort Gottardo, Nicholas G.
collection PubMed
description
format Online
Article
Text
id pubmed-9807471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98074712023-01-04 Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials Gottardo, Nicholas G. Acta Neuropathol Correspondence Springer Berlin Heidelberg 2022-11-20 2023 /pmc/articles/PMC9807471/ /pubmed/36403175 http://dx.doi.org/10.1007/s00401-022-02518-0 Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Gottardo, Nicholas G.
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title_full Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title_fullStr Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title_full_unstemmed Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title_short Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
title_sort genetic alterations of tp53 and otx2 indicate increased risk of relapse in wnt medulloblastomas: “it’s a numbers game”—implications for wnt medulloblastoma dose-reduction clinical trials
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807471/
https://www.ncbi.nlm.nih.gov/pubmed/36403175
http://dx.doi.org/10.1007/s00401-022-02518-0
work_keys_str_mv AT gottardonicholasg geneticalterationsoftp53andotx2indicateincreasedriskofrelapseinwntmedulloblastomasitsanumbersgameimplicationsforwntmedulloblastomadosereductionclinicaltrials

Ejemplares similares